Drugs News and Research

RSS

Oxaliplatin and bevacizumab disappoint for rectal cancer

The addition of bevacizumab and oxaliplatin to standard neoadjuvant chemoradiotherapy does not enhance clinical response rates in rectal cancer, show phase II study results.

9 Jan 2013

Improving access to medical abortion

"In many countries, government policies, and societal practices do not uphold women's right not to continue a pregnancy and women with unwanted pregnancies are forced into motherhood," but "[f]ortunately for women, ... abortion with pills, also known as medical abortion (MA), provides a safe, low-cost and easy to use method to terminate pregnancies," Leila Hessini and Alyson Hyman of Ipas write in an RH Reality Check post.

9 Jan 2013

Kingston University professor receives prestigious prize for work on drug metabolism

The Dean of the Faculty of Science, Engineering and Computing at London's Kingston University has received a prestigious prize recognising her lifetime's work on drug metabolism.

9 Jan 2013

Researchers develop new materials to support stem cell growth

Stem cell manufacturing for drug screening and treatments for diseases such as Huntington's and Parkinson's could be boosted by a new method of generating stem cells, a study suggests.

9 Jan 2013

Uganda government continuing focus on HIV prevention, treatment, amid calls from groups to do more

"Uganda continues to fall short of achieving its goal of ensuring that 80 percent of people living with HIV receive antiretroviral drugs (ARVs) by 2015, according to the Uganda AIDS Commission (UAC)," PlusNews reports.

9 Jan 2013

New scoring system can help clinicians better identify non-ICU patients at risk for GI bleeding

Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.

9 Jan 2013

Wockhardt receives final FDA approval for Lamotrigine to treat epilepsy

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy.

9 Jan 2013

Patient requests, drug company ties likely to influence doctors' decision to prescribe name-brand drugs

When patients ask for a brand-name drug, many physicians give in rather than prescribe a generic, according to a nationwide survey, and in-office promotions to doctors increase the likelihood.

9 Jan 2013

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Boehringer Ingelheim and Eli Lilly and Company today announced top-line results for four completed Phase III clinical trials for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor being studied for treatment of patients with Type 2 Diabetes (T2D).

9 Jan 2013

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer

A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a Mayo Clinic-led study published in the journal Science Translational Medicine.

9 Jan 2013

Dopamine-related drug exposure, Parkinson's increase risk of impulse control problems

Parkinson's disease itself does not increase the risk of impulse control problems such as compulsive gambling and shopping that have been seen in people taking certain drugs for Parkinson's disease, according to new research published in the January 8, 2013, print issue of Neurology, the medical journal of the American Academy of Neurology.

9 Jan 2013

Mass. governor proposes new compounding pharmacy oversights

Massachusetts Gov. Deval Patrick is proposing the state exercise stricter control over compounding pharmacies by -- in part -- establishing new licensing requirements for the labs and letting the state assess fines against them if they break rules.

9 Jan 2013

Beta blockers can reduce risk of Alzheimer's, other types of dementia

People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.

9 Jan 2013

Researchers use electrokinetic patterning to separate particles and microbes by size

Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research.

9 Jan 2013

New compound restores health of mice with MRSA infection

Researchers have discovered a new compound that restores the health of mice infected with methicillin-resistant Staphylococcus aureus (MRSA), an otherwise dangerous bacterial infection. The new compound targets an enzyme not found in human cells but which is essential to bacterial survival.

8 Jan 2013

SNSF-funded professor to receive 2012 National Latsis Prize

On 10 January 2013, Jacques Fellay will receive the National Latsis Prize 2012 at the Rathaus in Berne. The Swiss National Science Foundation (SNSF) is awarding the Prize to the SNSF-funded professor at EPF Lausanne in recognition of his work on the human genome and its defence mechanisms against viral diseases such as AIDS.

8 Jan 2013

Drugs News and Research

Oxaliplatin and bevacizumab disappoint for rectal cancer

Improving access to medical abortion

Kingston University professor receives prestigious prize for work on drug metabolism

Researchers develop new materials to support stem cell growth

Uganda government continuing focus on HIV prevention, treatment, amid calls from groups to do more

New scoring system can help clinicians better identify non-ICU patients at risk for GI bleeding

Wockhardt receives final FDA approval for Lamotrigine to treat epilepsy

Patient requests, drug company ties likely to influence doctors' decision to prescribe name-brand drugs

Lilly, Boehringer Ingelheim announce top-line results from empagliflozin Phase III trials on T2D

Combination of pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer

Dopamine-related drug exposure, Parkinson's increase risk of impulse control problems

Mass. governor proposes new compounding pharmacy oversights

Beta blockers can reduce risk of Alzheimer's, other types of dementia

Researchers use electrokinetic patterning to separate particles and microbes by size

New compound restores health of mice with MRSA infection

SNSF-funded professor to receive 2012 National Latsis Prize

Cost-ineffective drug prescribing practices revealed

Al Jazeera examines HIV in Russia

Dementia diagnosis: an interview with Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition

Researchers identify protein that helps prevent obesity

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News